{"groups":[{"description":"thalidomide/dexamethasone followed by tandem melphalan peripheral blood stem cell transplantation (with cyclophosphamide and filgrastim or sargramostim support) and prednisone/thalidomide maintenance","id":"FG000","title":"Treatment Arm"}],"periods":[{"milestones":[{"achievements":[{"comment":"147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.","groupId":"FG000","numSubjects":"147"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"110"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"37"}],"type":"NOT COMPLETED"}],"title":"Induction/PBSC Mobilization"},{"milestones":[{"achievements":[{"comment":"108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.","groupId":"FG000","numSubjects":"108"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"77"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"31"}],"type":"NOT COMPLETED"}],"title":"Autologous PBSCT"},{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"76"}],"type":"STARTED"},{"achievements":[{"comment":"Patients remained on protocol therapy until progression.","groupId":"FG000","numSubjects":"76"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Maintenance"}],"recruitmentDetails":"Patients were recruited at participating cooperative group institutions."}